IP Library Granted Patent US 8,556,881
Granted Patent B2
US 8,556,881 · App. 13/369,201 · Granted Oct 15, 2013

Catheter guidance through a calcified aortic valve

Inventor: Randall T. Lashinski (Santa Rosa, CA)
Assignee: Direct Flow Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,556,881
App. No.
13/369,201
Granted
Oct 15, 2013
Kind
B2
Abstract

A method of treating a patient with a calcified aortic valve includes introducing a guide wire into a blood vessel. The guide wire is advanced through the aorta to the aortic valve and then through the aortic valve. A balloon dilatation catheter is introduced into the blood vessel over the guide wire. The balloon dilatation catheter includes an elongate body, a distal portion, a guide wire lumen, an inflation lumen, and a dilatation balloon. The balloon dilatation catheter further includes at least one deflection wire lumen, and at least one deflection wire residing in the at least one deflection wire lumen and having a distal end attached to the distal portion. The balloon dilatation catheter is advanced over the guide wire through the aorta, through the aortic valve, and the dilatation balloon is inflated.

Claims (12)

1. A method of treating a patient with a calcified aortic valve, the method comprising:

introducing a guide wire into a blood vessel;

advancing the guide wire through the aorta to the aortic valve;

advancing the guide wire through the aortic valve;

introducing a catheter into the blood vessel over the guide wire, the catheter comprising an elongate body, a distal portion, a guide wire lumen, at least one deflection wire lumen, and at least one deflection wire residing in the at least one deflection wire lumen and having a distal end directly attached to the distal portion;

advancing the catheter over the guide wire through the aorta;

actuating the at least one deflection wire; and

advancing the catheter through the aortic valve, wherein actuating the at least one deflection wire occurs prior to advancing the catheter through the aortic valve.

2. The method of claim 1 , wherein the catheter further comprises a dilatation balloon.

3. The method of claim 2 , further comprises inflating the dilatation balloon.

4. The method of claim 1 , wherein the catheter carries an implantable prosthetic valve.

5. The method of claim 4 , further comprises deploying the implantable prosthetic valve.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2020
From: DFM, LLC
To: SPEYSIDE MEDICAL LLC
Reel/Frame 051882/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2017
From: DIRECT FLOW MEDICAL, INC.
To: DIRECT FLOW (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 041080/0644 →
TRANSFER STATEMENT PURSUANT TO SECTION 9-619 OF THE UNIFORM COMMERCIAL CODE Recorded Jan 25, 2017
From: DIRECT FLOW (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: DFM, LLC
Reel/Frame 041483/0220 →
SECURITY AGREEMENT Recorded Nov 5, 2013
From: DIRECT FLOW MEDICAL, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 031583/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2013
From: LASHINSKI, RANDALL T.
To: DIRECT FLOW MEDICAL, INC.
Reel/Frame 031177/0684 →
Continuity (3)
Continuation 11874825 · Oct 18, 2007
Provisional Application 60862187 · Oct 19, 2006
Related Publication 20120203263A1 · Aug 9, 2012